Sagimet updates investor presentation; no specifics disclosed

Sagimet Biosciences Inc.

Filed Item 7.01 with investor presentation dated April 2026.
No financial or clinical data detailed in the filing or exhibit excerpt.
Presentation slides not reproduced; materiality cannot be assessed.

item 7.01 item 9.01

Sagimet Biosciences Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-049015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.